Elevance Health finds itself in a charmingly awkward “Moderate Buy” spotlight, courted by 17 analysts, 13 of whom are smitten ...

J. Safra Sarasin Holding AG has decided to take a first-class seat on Boeing’s financial flight, acquiring 5,654 shares ...

Bolthouse Investments dropped a cool $287,000 on TJX Companies during the fourth quarter, nabbing 2,378 shares of the ...

OneDigital Investment Advisors LLC trimmed its Deere & Company holdings by 13.6% during the fourth quarter, selling 911 ...

Vertex Pharmaceuticals is expected to report mixed results with declining earnings but rising revenues for Q1 2025. Analysts ...

Representative George Whitesides recently cleaned house, selling off shares of Lockheed Martin and other major corporations.

NewEdge Advisors LLC significantly reduced its stake in Regeneron Pharmaceuticals, shedding shares like unwanted holiday weight. The firm sold 1,630 shares, cutting its holdings by 36.8%, leaving it ...

Bristol-Myers Squibb managed to surpass revenue expectations by a comfortable 4.6%, yet suffered an inconvenient earnings ...

Cigna Group sees mixed insider activity as former officer Michael W. Triplett injects a $0.27 million dose into company ...

Kovitz Investment Group Partners brewed up a financial storm by dramatically increasing their Starbucks shares in Q4. Their ...

Automatic Data Processing (ADP) will announce quarterly earnings on April 30, with analysts forecasting revenue of $5.55 ...

Marsh & McLennan saw its stock position rise modestly, driven by MML Investors Services boosting shares by 2.8%. However, executives had other ideas, with CEOs Nicholas Studer and Dean Klisura selling ...